SCHEMBL21367139

SCHEMBL21367139

CNC(=O)[C@H]1O[C@@H](n2ccc3c(Cl)ncnc32)[C@@H]2OC(C)(C)O[C@@H]21

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 14/20 0.46
▸ WDR77 Q9BQA1 14/20 0.46
▸ METTL3 Q86U44 1/20 0.38
▸ ADORA3 P0DMS8 2/20 0.38
▸ ADORA1 P30542 2/20 0.38
▸ TSHR P16473 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ HSP90AA1 P07900 1/20 0.38
▸ HSP90B1 P14625 1/20 0.38
▸ AHCY P23526 1/20 0.38
▸ ADORA2A P29274 1/20 0.38
▸ ADORA2B P29275 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18009766 0.89 PRMT5 (0.43) PRMT5WDR77
SCHEMBL18205070 0.86 PRMT5 (0.42) PRMT5WDR77
SCHEMBL22002026 0.85 PRMT5 (0.41) PRMT5WDR77
SCHEMBL18205028 0.84 PRMT5 (0.42) PRMT5WDR77
SCHEMBL18205090 0.83 PRMT5 (0.40) PRMT5WDR77
SCHEMBL24489756 0.83 PRMT5 (0.41) PRMT5WDR77ADORA3ADORA1
SCHEMBL21367135 0.83 PRMT5 (0.41) PRMT5WDR77ADORA3ADORA1
SCHEMBL21367292 0.83 PRMT5 (0.41) PRMT5WDR77ADORA3ADORA1
SCHEMBL18205046 0.83 PRMT5 (0.40) PRMT5WDR77
SCHEMBL21367163 0.83 PRMT5 (0.41) PRMT5WDR77ADORA3ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3765461-B1 SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) PRELUDE THERAPEUTICS INC (US) 2023-08-30 — — EP disclosed
WO-2019178368-A1 SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) PRELUDE THERAPEUTICS, INCORPORATED (US) 2019-09-19 — — WO disclosed
Send feedback